199 related articles for article (PubMed ID: 24379144)
1. High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.
Labots M; Buffart TE; Haan JC; van Grieken NC; Tijssen M; van de Velde CJ; Grabsch HI; Ylstra B; Carvalho B; Fijneman RJ; Verheul HM; Meijer GA
Cell Oncol (Dordr); 2014 Feb; 37(1):41-52. PubMed ID: 24379144
[TBL] [Abstract][Full Text] [Related]
2. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.
Fan B; Dachrut S; Coral H; Yuen ST; Chu KM; Law S; Zhang L; Ji J; Leung SY; Chen X
PLoS One; 2012; 7(4):e29824. PubMed ID: 22539939
[TBL] [Abstract][Full Text] [Related]
3. Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type.
Jin DH; Park SE; Lee J; Kim KM; Kim S; Kim DH; Park J
PLoS One; 2015; 10(9):e0137657. PubMed ID: 26360582
[TBL] [Abstract][Full Text] [Related]
4. Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer.
Buffart TE; Carvalho B; van Grieken NC; van Wieringen WN; Tijssen M; Kranenbarg EM; Verheul HM; Grabsch HI; Ylstra B; van de Velde CJ; Meijer GA
Oncologist; 2012; 17(5):653-62. PubMed ID: 22531355
[TBL] [Abstract][Full Text] [Related]
5. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer.
Chen Z; Huang W; Tian T; Zang W; Wang J; Liu Z; Li Z; Lai Y; Jiang Z; Gao J; Shen L
J Hematol Oncol; 2018 Feb; 11(1):20. PubMed ID: 29433585
[TBL] [Abstract][Full Text] [Related]
6. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
[TBL] [Abstract][Full Text] [Related]
8. Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH).
Bibi F; Ali I; Naseer MI; Ali Mohamoud HS; Yasir M; Alvi SA; Jiman-Fatani AA; Sawan A; Azhar EI
PLoS One; 2018; 13(9):e0202576. PubMed ID: 30212456
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic analysis of primary tumors and metastases in breast cancer.
Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
[TBL] [Abstract][Full Text] [Related]
10. DNA copy number changes in gastric adenocarcinomas: high resolution-comparative genomic hybridization study in Turkey.
Gümüs-Akay G; Unal AE; Elhan AH; Bayar S; Karadayt K; Sunguroglu A; Kadikiran A; Tükün A
Arch Med Res; 2009 Oct; 40(7):551-60. PubMed ID: 20082868
[TBL] [Abstract][Full Text] [Related]
11. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
[TBL] [Abstract][Full Text] [Related]
13. Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.
Hescheler DA; Plum PS; Zander T; Quaas A; Korenkov M; Gassa A; Michel M; Bruns CJ; Alakus H
Gastric Cancer; 2020 Jul; 23(4):627-638. PubMed ID: 32107691
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.
Deng N; Goh LK; Wang H; Das K; Tao J; Tan IB; Zhang S; Lee M; Wu J; Lim KH; Lei Z; Goh G; Lim QY; Tan AL; Sin Poh DY; Riahi S; Bell S; Shi MM; Linnartz R; Zhu F; Yeoh KG; Toh HC; Yong WP; Cheong HC; Rha SY; Boussioutas A; Grabsch H; Rozen S; Tan P
Gut; 2012 May; 61(5):673-84. PubMed ID: 22315472
[TBL] [Abstract][Full Text] [Related]
15. Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer.
Rossi E; Klersy C; Manca R; Zuffardi O; Solcia E
Hum Pathol; 2011 Dec; 42(12):1937-45. PubMed ID: 21676433
[TBL] [Abstract][Full Text] [Related]
16. An integrative approach identified genes associated with drug response in gastric cancer.
Zhou J; Yong WP; Yap CS; Vijayaraghavan A; Sinha RA; Singh BK; Xiu S; Manesh S; Ngo A; Lim A; Ang C; Xie C; Wong FY; Lin SJ; Wan WK; Tan IB; Flotow H; Tan P; Lim KH; Yen PM; Goh LK
Carcinogenesis; 2015 Apr; 36(4):441-51. PubMed ID: 25742747
[TBL] [Abstract][Full Text] [Related]
17. Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas.
Kokkola A; Monni O; Puolakkainen P; Nordling S; Haapiainen R; Kivilaakso E; Knuutila S
Cancer Genet Cytogenet; 1998 Nov; 107(1):32-6. PubMed ID: 9809031
[TBL] [Abstract][Full Text] [Related]
18. High-density array comparative genomic hybridization detects novel copy number alterations in gastric adenocarcinoma.
Seabra AD; Araújo TM; Mello Junior FA; Di Felipe Ávila Alcântara D; De Barros AP; De Assumpção PP; Montenegro RC; Guimarães AC; Demachki S; Burbano RM; Khayat AS
Anticancer Res; 2014 Nov; 34(11):6405-15. PubMed ID: 25368240
[TBL] [Abstract][Full Text] [Related]
19. Identification of genes with a correlation between copy number and expression in gastric cancer.
Cheng L; Wang P; Yang S; Yang Y; Zhang Q; Zhang W; Xiao H; Gao H; Zhang Q
BMC Med Genomics; 2012 May; 5():14. PubMed ID: 22559327
[TBL] [Abstract][Full Text] [Related]
20. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y
Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
